These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 35714473)
61. Tailored Melatonin- and Donepezil-Based Hybrids Targeting Pathognomonic Changes in Alzheimer's Disease: An In Vitro and In Vivo Investigation. Mihaylova R; Angelova VT; Tchekalarova J; Atanasova D; Ivanova P; Simeonova R Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892154 [TBL] [Abstract][Full Text] [Related]
62. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034 [TBL] [Abstract][Full Text] [Related]
63. Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity. Chaves S; Várnagy K; Santos MA Curr Med Chem; 2021; 28(35):7247-7277. PubMed ID: 33602068 [TBL] [Abstract][Full Text] [Related]
64. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease. Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830 [TBL] [Abstract][Full Text] [Related]
72. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease. Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948 [TBL] [Abstract][Full Text] [Related]
73. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. Knez D; Coquelle N; Pišlar A; Žakelj S; Jukič M; Sova M; Mravljak J; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S Eur J Med Chem; 2018 Aug; 156():598-617. PubMed ID: 30031971 [TBL] [Abstract][Full Text] [Related]
74. Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies. Pravin N; Jozwiak K Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682763 [TBL] [Abstract][Full Text] [Related]
75. Semi-synthesis and biological evaluation of flavone hybrids as multifunctional agents for the potential treatment of Alzheimer's disease. Shi S; Wang H; Wang J; Wang Y; Xue X; Hou Z; Yao GD; Huang XX; Zhao H; Liu Q; Song SJ Bioorg Chem; 2020 Jul; 100():103917. PubMed ID: 32442817 [TBL] [Abstract][Full Text] [Related]
76. Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment. Montanari S; Mahmoud AM; Pruccoli L; Rabbito A; Naldi M; Petralla S; Moraleda I; Bartolini M; Monti B; Iriepa I; Belluti F; Gobbi S; Di Marzo V; Bisi A; Tarozzi A; Ligresti A; Rampa A Eur J Med Chem; 2019 Sep; 178():243-258. PubMed ID: 31185414 [TBL] [Abstract][Full Text] [Related]
77. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease. Weinreb O; Amit T; Bar-Am O; Youdim MB Br J Pharmacol; 2016 Jul; 173(13):2080-94. PubMed ID: 26332830 [TBL] [Abstract][Full Text] [Related]
78. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties. Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057 [TBL] [Abstract][Full Text] [Related]
79. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease. Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075 [TBL] [Abstract][Full Text] [Related]
80. Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress. Sang Z; Wang K; Dong J; Tang L Eur J Med Chem; 2022 Aug; 238():114464. PubMed ID: 35635955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]